Proteomics

Dataset Information

0

Comparative proteome of membrane proteome from Lactobacillus fermentum MI37


ABSTRACT: Recent findings have positioned the gut microbiota as a promising target to enhance cancer immunotherapy. However, the specific microbial molecules that drive anti-tumor immunity remain unclear. Here, we identify a human-derived strain, Lactobacillus fermentum MI37, that potentiates anti-cancer immune responses and synergizes with anti-PD-1 immune checkpoint blockade. MI37 robustly induces IFN-γ production by splenocytes, with minimal IL-10 induction, and enhances cytotoxic T lymphocyte infiltration and inflammatory gene expression within tumors in a syngeneic mouse model. Remarkably, heat-killed MI37 retains its immunostimulatory effects and anti-tumor efficacy. Fractionation experiments implicate lipoteichoic acid (LTA) as the active component, and LTA mimics the effects of MI37 on IFN-γ production and CD8⁺ T cell activation. Genomic and proteomic profiling reveals MI37-specific pathways involved in teichoic acid biosynthesis, including a unique sulfatase N-terminal domain-containing protein with an LTA synthase domain. These findings highlight the potential of LTA-producing probiotics as microbial adjuvants to improve the efficacy of cancer immunotherapy.

INSTRUMENT(S):

ORGANISM(S): Escherichia Coli

TISSUE(S): Cell Culture

SUBMITTER: Kyunggon Kim  

LAB HEAD: Kyunggon Kim

PROVIDER: PXD071250 | Pride | 2026-05-25

REPOSITORIES: Pride

Dataset's files

Source:
altmetric image

Publications

Newly isolated human-derived <i>Lactobacillus fermentum</i> strain stimulates IFN-γ-secreting CD8<sup>+</sup> T cells for enhanced anti-cancer immunity.

Kim Tae-Young TY   Kim Seungil S   Lee Sohyeon S   Lee Su-Hyun SH   Yu Jiyoung J   Kim Kyunggon K   Kweon Mi-Na MN  

iScience 20260408 5


The gut microbiota represents a promising target to enhance cancer immunotherapy, yet the microbial molecules mediating anti-tumor immunity remain poorly defined. Here, we identify a human-derived strain, <i>Lactobacillus fermentum</i> MI37, that augments anti-tumor immune responses and synergizes with anti-PD-1 therapy. MI37 induces robust IFN-γ production with minimal IL-10, increases tumor-infiltrating cytotoxic T lymphocytes, and upregulates inflammatory gene programs in a syngeneic mouse mo  ...[more]

Similar Datasets

2018-11-22 | PXD006912 | Pride
2018-11-22 | PXD006913 | Pride
2018-10-24 | GSE121694 | GEO
2013-09-24 | E-GEOD-51102 | biostudies-arrayexpress
2023-02-17 | E-MTAB-12569 | biostudies-arrayexpress
2024-04-02 | GSE262545 | GEO
2022-06-29 | GSE186497 | GEO
2023-07-01 | E-MTAB-13050 | biostudies-arrayexpress
2021-09-10 | PXD024647 | Pride
2021-09-09 | PXD020750 | Pride